To identify reliable markers of LRRK2 activity in human CSF.

To identify reliable markers of LRRK2 activity in human CSF.
Recruiting
30 years - 99 years
All
Phase N/A
30 participants needed
1 Location

Brief description of study

The purpose of this research study is to evaluate new tests for Parkinson's disease (PD) that may help in developing better treatments.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Parkinsons
  • Age: 30 years - 99 years
  • Gender: All

  • Conditions: Parkinsons
  • Age: Between 30 - 99 Years
  • Gender: Male or Female

Updated on 04 Aug 2024. Study ID: 844136

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center